Join the Family Office Networks’ Webinar Series featuring Psy Therapeutics, Inc.
Psy Therapeutics, Inc. is an emerging biopharmaceutical company focused on developing transformative medicines to treat serious neuropsychiatric disorders. The Company’s novel approach to customized small molecule drug discovery and development combines cutting-edge technology with an extensive network of collaborators to drive R&D innovation and productivity.
Mental illness and neurodegenerative disorders continue to wreak havoc on patients, their families, and our society.
Introduction: tZERO Overview
Presentation Led by tZERO’s Business Development & Capital Markets Team
Panel Discussion: ‘Advantages of Enabling Liquidity of Private Assets’
Discussion with Panelists:
Michael Gaviser, Former KKR Managing Director
Alan Konevsky, tZERO Chief Legal Officer
Hubertus Thonhauser, Tezos Foundation Council Chair Member
Keynote Presentation: ‘The Future of Investments & Trading’
Keynote Led by John Jacobs, Former Nasdaq EVP
Join the Family Office Networks’ Webinar Series to learn more about tZERO, a leader in financial innovation and liquidity for private companies. tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) offers institutional-grade solutions for issuers looking to digitize their capital table and trade on a regulated alternative trading system. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. TRAC is a new kind of quantitative early-stage venture firm. The unique predictive technology combines superhuman forecasters and machine intelligence to accurately predict future unicorns early and with an overall accuracy 60%.
